381 related articles for article (PubMed ID: 11085753)
21. Chemokine and chemokine receptor gene expression indicates acute rejection of human cardiac transplants.
Fahmy NM; Yamani MH; Starling RC; Ratliff NB; Young JB; McCarthy PM; Feng J; Novick AC; Fairchild RL
Transplantation; 2003 Jan; 75(1):72-8. PubMed ID: 12544874
[TBL] [Abstract][Full Text] [Related]
22. Recruitment of CXCR3+ and CCR5+ T cells and production of interferon-gamma-inducible chemokines in rejecting human arteries.
Burns WR; Wang Y; Tang PC; Ranjbaran H; Iakimov A; Kim J; Cuffy M; Bai Y; Pober JS; Tellides G
Am J Transplant; 2005 Jun; 5(6):1226-36. PubMed ID: 15888026
[TBL] [Abstract][Full Text] [Related]
23. Prolonged allograft survival in TNF receptor 1-deficient recipients is due to immunoregulatory effects, not to inhibition of direct antigraft cytotoxicity.
McKee CM; Defina R; He H; Haley KJ; Stone JR; Perkins DL
J Immunol; 2002 Jan; 168(1):483-9. PubMed ID: 11751996
[TBL] [Abstract][Full Text] [Related]
24. T cell infiltration into class II MHC-disparate allografts and acute rejection is dependent on the IFN-gamma-induced chemokine Mig.
Koga S; Auerbach MB; Engeman TM; Novick AC; Toma H; Fairchild RL
J Immunol; 1999 Nov; 163(9):4878-85. PubMed ID: 10528189
[TBL] [Abstract][Full Text] [Related]
25. Combined CXCR3/CCR5 blockade attenuates acute and chronic rejection.
Schnickel GT; Bastani S; Hsieh GR; Shefizadeh A; Bhatia R; Fishbein MC; Belperio J; Ardehali A
J Immunol; 2008 Apr; 180(7):4714-21. PubMed ID: 18354195
[TBL] [Abstract][Full Text] [Related]
26. CCR4-deficient mice show prolonged graft survival in a chronic cardiac transplant rejection model.
Hüser N; Tertilt C; Gerauer K; Maier S; Traeger T; Assfalg V; Reiter R; Heidecke CD; Pfeffer K
Eur J Immunol; 2005 Jan; 35(1):128-38. PubMed ID: 15593118
[TBL] [Abstract][Full Text] [Related]
27. Serum levels of CXCR3 ligands predict T cell-mediated acute rejection after kidney transplantation.
Huang H; Xu X; Yao C; Cai M; Qian Y; Wang X; Shi B
Mol Med Rep; 2014 Jan; 9(1):45-50. PubMed ID: 24154640
[TBL] [Abstract][Full Text] [Related]
28. Prolongation of cardiac and islet allograft survival by a blocking hamster anti-mouse CXCR3 monoclonal antibody.
Uppaluri R; Sheehan KC; Wang L; Bui JD; Brotman JJ; Lu B; Gerard C; Hancock WW; Schreiber RD
Transplantation; 2008 Jul; 86(1):137-47. PubMed ID: 18622291
[TBL] [Abstract][Full Text] [Related]
29. A role for fractalkine and its receptor (CX3CR1) in cardiac allograft rejection.
Robinson LA; Nataraj C; Thomas DW; Howell DN; Griffiths R; Bautch V; Patel DD; Feng L; Coffman TM
J Immunol; 2000 Dec; 165(11):6067-72. PubMed ID: 11086038
[TBL] [Abstract][Full Text] [Related]
30. Altered distribution of H60 minor H antigen-specific CD8 T cells and attenuated chronic vasculopathy in minor histocompatibility antigen mismatched heart transplantation in Cxcr3-/- mouse recipients.
Kwun J; Hu H; Schadde E; Roenneburg D; Sullivan KA; DeMartino J; Burlingham WJ; Knechtle SJ
J Immunol; 2007 Dec; 179(12):8016-25. PubMed ID: 18056341
[TBL] [Abstract][Full Text] [Related]
31. Noninvasive detection of renal allograft inflammation by measurements of mRNA for IP-10 and CXCR3 in urine.
Tatapudi RR; Muthukumar T; Dadhania D; Ding R; Li B; Sharma VK; Lozada-Pastorio E; Seetharamu N; Hartono C; Serur D; Seshan SV; Kapur S; Hancock WW; Suthanthiran M
Kidney Int; 2004 Jun; 65(6):2390-7. PubMed ID: 15149352
[TBL] [Abstract][Full Text] [Related]
32. CXCR3 antagonism impairs the development of donor-reactive, IFN-gamma-producing effectors and prolongs allograft survival.
Rosenblum JM; Zhang QW; Siu G; Collins TL; Sullivan T; Dairaghi DJ; Medina JC; Fairchild RL
Transplantation; 2009 Feb; 87(3):360-9. PubMed ID: 19202440
[TBL] [Abstract][Full Text] [Related]
33. The chemokine receptor Cxcr3 is not essential for acute cardiac allograft rejection in mice and rats.
Zerwes HG; Li J; Kovarik J; Streiff M; Hofmann M; Roth L; Luyten M; Pally C; Loewe RP; Wieczorek G; Bänteli R; Thoma G; Luckow B
Am J Transplant; 2008 Aug; 8(8):1604-13. PubMed ID: 18557719
[TBL] [Abstract][Full Text] [Related]
34. Intraallograft chemokine RNA and protein during rejection of MHC-matched/multiple minor histocompatibility-disparate skin grafts.
Watarai Y; Koga S; Paolone DR; Engeman TM; Tannenbaum C; Hamilton TA; Fairchild RL
J Immunol; 2000 Jun; 164(11):6027-33. PubMed ID: 10820287
[TBL] [Abstract][Full Text] [Related]
35. Donor T cell activation initiates small bowel allograft rejection through an IFN-gamma-inducible protein-10-dependent mechanism.
Zhang Z; Kaptanoglu L; Haddad W; Ivancic D; Alnadjim Z; Hurst S; Tishler D; Luster AD; Barrett TA; Fryer J
J Immunol; 2002 Apr; 168(7):3205-12. PubMed ID: 11907073
[TBL] [Abstract][Full Text] [Related]
36. Memory T cells migrate to and reject vascularized cardiac allografts independent of the chemokine receptor CXCR3.
Oberbarnscheidt MH; Walch JM; Li Q; Williams AL; Walters JT; Hoffman RA; Demetris AJ; Gerard C; Camirand G; Lakkis FG
Transplantation; 2011 Apr; 91(8):827-32. PubMed ID: 21285915
[TBL] [Abstract][Full Text] [Related]
37. Absence of recipient CCR5 promotes early and increased allospecific antibody responses to cardiac allografts.
Amano H; Bickerstaff A; Orosz CG; Novick AC; Toma H; Fairchild RL
J Immunol; 2005 May; 174(10):6499-508. PubMed ID: 15879153
[TBL] [Abstract][Full Text] [Related]
38. Permanent survival of fully MHC-mismatched islet allografts by targeting a single chemokine receptor pathway.
Wang L; Han R; Lee I; Hancock AS; Xiong G; Gunn MD; Hancock WW
J Immunol; 2005 Nov; 175(10):6311-8. PubMed ID: 16272282
[TBL] [Abstract][Full Text] [Related]
39. Differential expression of chemokines and chemokine receptors shapes the inflammatory response in rejecting human liver transplants.
Goddard S; Williams A; Morland C; Qin S; Gladue R; Hubscher SG; Adams DH
Transplantation; 2001 Dec; 72(12):1957-67. PubMed ID: 11773896
[TBL] [Abstract][Full Text] [Related]
40. Cxcr3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection.
Agostini C; Calabrese F; Rea F; Facco M; Tosoni A; Loy M; Binotto G; Valente M; Trentin L; Semenzato G
Am J Pathol; 2001 May; 158(5):1703-11. PubMed ID: 11337368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
